Mizuho’s Jared Holz joins the ‘Fast Money’ team to discuss the potential impact of expiring patents within the biotech and pharmaceuticals industries.
Trending
- Fund managers say companies are overinvesting—BofA survey
- Hong Kong IPO boom offers lifeline to China private equity exits
- Europe has rare earths but, for now, it’s at China’s mercy
- Dubai Airports targets annual traffic of 124 million by 2032: CEO
- AI firms are getting money while their stocks are losing value
- UK inflation at 3.6% in October, boosting chance of December rate cut
- Stoxx 600, FTSE, DAX, CAC, Nvidia earnings
- Britain’s Reeves paints a confusing picture as pressure builds from all sides
Mizuho’s Jared Holz details potential biotech, pharma acquisitions
